The capability centre, called ‘the Analytics Gateway’ will serve all of Pfizer’s international (ex-US) markets to bring analytics, and insight breakthroughs that will benefit patients.
The Analytics Gateway comprises a talented and experienced pool of data and analytics experts, and is expected to accelerate data science and AI solutions to meet Pfizer’s ambitions in modernizing marketing and creating an agile sales force.
It will also drive continuous commercial effectiveness, enabling Pfizer to bring more of its medicines to more patients in India and around the world.
“The Analytics Gateway is an important catalyst to reshape healthcare, transforming how we deliver breakthroughs at lightspeed, enabling us to deliver life-changing therapies to patients,” said Xingchu Liu, chief commercial analytics & AI officer.
“We are confident that the setup of this capability center in India will have a positive impact on Pfizer’s ability to make informed, data-driven decisions that will prove valuable to patients and customers around the world,” Liu added.“It is an important recognition of the skilled talent in data science and analytics that India can offer to the globe, and strengthens Pfizer’s presence in our country,” Meenakshi Nevatia, country president, Pfizer India, said.